Assay of Plasma Phosphorylated Tau Protein (Threonine 181) and Total Tau Protein in Early-Stage Alzheimer’s Disease

Written By Yiran Gan
Assay of Plasma Phosphorylated Tau Protein (Threonine 181) and Total Tau Protein in Early-Stage Alzheimer's Disease - Yang et al. 2018

Assay of Plasma Phosphorylated Tau Protein (Threonine 181) and Total Tau Protein in Early-Stage Alzheimer's Disease

Publication Date: 2018.01.31

Authors: C. C. Yang, M. J. Chiu, T. F. Chen, H. L Chang, B. H. Liu, S. Y Yang

Journal: J Alzheimers Dis. 61(4):1323-1332 (2018)

Citation

C. C. Yang, M. J. Chiu, T. F. Chen, H. L Chang, B. H. Liu, S. Y Yang, "Assay of Plasma Phosphorylated Tau Protein (Threonine 181) and Total Tau Protein in Early-Stage Alzheimer's Disease", J Alzheimers Dis. 61(4):1323-1332. (2018).

Article Link

J Alzheimers Dis. 61(4):1323-1332

© 2018 Yang, Chiu, Chen, Chang, Liu, and Yang

Journal of Alzheimer's Disease | Volume 61, Issue 4, Pages 1323-1332

Yiran Gan
Previous

Characterization of magnetic relaxation when biofunctionalized magnetic nano-particles are associated with biomarkers in the liquid state in biomedical applications
Next

Potential applications of magnetic particles to detect and treat Alzheimer's disease